2026 IPO Issuance Nears All-Time Record as SpaceX Lockup Test Approaches

Through July 10, 2026, operating companies have raised $140 billion in IPOs — 91% of it on Nasdaq — putting the year within striking distance of 2021’s full-year record of $141 billion in just over six months.{{cite:b389abe817d3}} The surge is dominated by two historic deals but is not dependent on them alone, and the second half now hinges on a structural event that has nothing to do with fundamentals: the first SpaceX insider lockup window, expected to open around the company’s first post-IPO earnings in early August.

The Numbers: A Record-Adjacent Year

The headline figures are extraordinary. In June, SpaceX (SPCX) raised $75 billion in its Nasdaq debut — $86 billion including the greenshoe — triple the previous record for the largest IPO, listing with a market cap of roughly $2 trillion.{{cite:b389abe817d3}} Weeks later, SKHY — the ADR for SK Hynix — raised $26.5 billion, the largest U.S. IPO ever by a foreign company.{{cite:b389abe817d3}} Between just those two issuers, over $100 billion was raised.

But the market is broader than two names. According to Dealogic data cited by ION Analytics, there were 194 IPOs in the U.S. through July 2, 2026, worth $155.8 billion.{{cite:85b0d0af0b75}} Even excluding SpaceX entirely, $69.9 billion of IPO paper was printed year-to-date — more than double the $31.6 billion raised over the same period in 2025.{{cite:85b0d0af0b75}} Since SpaceX’s debut, 19 additional IPOs priced on U.S. exchanges, raising a cumulative $6.9 billion, including the $1.68 billion listing of Italian digital holding company Bending Spoons and the $1 billion IPO of UK industrial manufacturer Doncasters Group.{{cite:85b0d0af0b75}}

The SEC’s own data confirms the trajectory from the regulatory side. In the first quarter of 2026, there were 99 IPOs raising over $22 billion, compared to 84 IPOs raising $11.8 billion in Q1 2025 — an approximately 86% increase in proceeds.{{cite:107436f72202}} Follow-on registered offerings also grew, with 264 deals raising over $44.2 billion in Q1 2026 versus 250 deals raising $40.4 billion a year earlier.{{cite:107436f72202}}

Nasdaq’s IPO Pulse — a cyclical indicator tracking the leading drivers of IPO activity — remains just below its April 1.5-year high, suggesting the upswing in activity is likely to persist into late 2026.{{cite:b389abe817d3}} Q2 alone saw 42 operating-company IPOs raising $102 billion, a 60% increase in deal count over Q1’s 26.{{cite:b389abe817d3}}

SpaceX: Record IPO, Vanishing Post-Debut Premium

SpaceX priced at $135 on June 11 and began trading June 12, opening around $150.{{cite:7553640c54ae}} Shares briefly touched $225.64 in mid-June before retreating.{{cite:7553640c54ae}} By mid-July, the stock had given back roughly 36% from that peak and was trading in the mid-$140s, with reports of it touching $132.15 — below the IPO price — on an intraday basis.{{cite:7553640c54ae}}

The structural reason for this volatility is a nearly nonexistent public float. SpaceX issued only about 4% of its shares in the IPO, leaving a tiny freely tradeable pool relative to the company’s total equity.{{cite:7553640c54ae}} When SpaceX joined the Nasdaq-100 on July 7, passive fund managers tracking QQQ and related indexes were forced to buy; estimated forced buying from QQQ alone was roughly $4.3 billion.{{cite:7553640c54ae}} That index-driven demand provided a floor, but it is a one-time mechanical event, not ongoing organic buying.

Underneath the stock story is a complex three-segment business. SpaceX’s 2025 consolidated revenue was roughly $18.7 billion with about $6.6 billion in adjusted EBITDA, with Starlink (Connectivity) representing about 61% of total revenue.{{cite:7553640c54ae}} For Q1 2026, total consolidated revenue was $4.694 billion, with Starlink generating approximately $3.26 billion in revenue and $1.188 billion in segment operating income.{{cite:7553640c54ae}} The company reported approximately 10.3 million Starlink subscribers as of March 31, 2026, with service in 164 countries and territories.{{cite:7553640c54ae}}

The complication is the AI segment. Following the February 2026 xAI transaction, SpaceX now reports results across Space, Connectivity, and AI segments. In 2025, the AI segment reported an operating loss of approximately $6.355 billion.{{cite:7553640c54ae}} The market is effectively being asked to value a profitable satellite internet business, a capital-intensive launch program, and a frontier AI business burning capital aggressively — all under one ticker.

The Lockup Cliff: Why August 6 Matters for More Than SpaceX

The single most important structural variable in the IPO market right now is not a new filing or a macro print. It is a date: approximately August 6, when SpaceX is scheduled to report its first quarterly earnings as a public company, and when the first insider lockup window is expected to open shortly after that release.{{cite:7553640c54ae}}

SpaceX’s prospectus materials describe a phased approach: eligible insiders can begin selling a portion of their holdings after the first earnings release, with an additional performance-based tranche tied to the stock trading at least 30% above the $135 IPO price — i.e., $175.50 — for five of any ten consecutive trading days.{{cite:7553640c54ae}} A broader 180-day lockup is reported to expire December 8, 2026, while Elon Musk’s 6.4 billion shares remain locked until June 12, 2027.{{cite:ae6a65d6cb6e}}

The supply-demand equation that has been artificially tight since the IPO begins normalizing at that earnings/lockup window. This is not inherently bearish — fresh supply can attract institutional buyers who have been waiting on the sidelines — but it is the mechanism that transitions SPCX from a scarcity-priced stock to one where price discovery reflects broader selling pressure.

The reason this matters beyond SpaceX was stated plainly by an ECM banker cited in ION Analytics: “If SpaceX starts to trade down that could close the door for other AI issuers.”{{cite:85b0d0af0b75}} The entire AI-adjacent issuance thesis — the thing driving the 2026 surge — is anchored by SpaceX’s aftermarket performance. A clean lockup absorption validates the risk appetite that underwrites the deals behind it. A messy one tightens it.

The AI Pipeline: Anthropic First, OpenAI Leaning Toward 2027

Behind SpaceX, the pipeline is dominated by the two frontier AI labs that filed confidential IPO registrations in June 2026.

Anthropic filed on June 1, 2026, after a $65 billion funding round at a $965 billion valuation, with the company reportedly on pace for its first profitable quarter and projected Q2 revenue of $10.9 billion.{{cite:0a348a50dbcc}} Reports track Anthropic toward an October offering, which would make it the first pure-play frontier lab to trade publicly.{{cite:30aad0e27335}}

OpenAI filed confidentially on June 8, 2026, but appears to be hesitating. Morningstar reports that OpenAI executives are signaling intent to wait until 2027 if the company cannot achieve a valuation north of $1 trillion.{{cite:30aad0e27335}} According to PitchBook data, OpenAI’s most recent funding round valued it at $852 billion as of March 2026, while Anthropic reached $965 billion in late May.{{cite:30aad0e27335}}

The gap is not just about headline valuation. Morningstar’s AI business quality framework scores Anthropic at 8.20 versus OpenAI at 4.53 on a 10-point scale measuring how efficiently a frontier lab turns capital into revenue and how durable that revenue is.{{cite:30aad0e27335}} Dividing each valuation by its score, OpenAI costs roughly $188 billion per quality point versus Anthropic’s $118 billion — about a 60% premium for the weaker business.{{cite:30aad0e27335}} OpenAI declining to test its price in the market is the first sign that investors may agree with that assessment.{{cite:30aad0e27335}}

A critical accounting question will be settled in Anthropic’s public prospectus this fall: revenue recognition. Anthropic includes revenue flowing through its cloud partners, while OpenAI counts only its direct share.{{cite:30aad0e27335}} OpenAI is valued at approximately 34 times its sales rate; Anthropic at roughly 20 times.{{cite:30aad0e27335}} If Anthropic’s inclusive revenue figure is overstated by roughly 40%, the gap would close — and its prospectus, public weeks before an October listing, will be the document that settles it.{{cite:30aad0e27335}}

The European Contrast

The U.S. surge stands in sharp relief to a European IPO market that remains structurally impaired. The most high-profile European deal expected before the summer break — Franco-German tank maker KNDS — was postponed, beset by poor trading among defense peers, German defense spending uncertainty, and the rise of asymmetric drone warfare displacing traditional armor demand.{{cite:85b0d0af0b75}}

Dealogic’s IPO Health Index for the Americas is now close to post-2021 highs, while the EMEA index sits near its post-2021 nadir.{{cite:85b0d0af0b75}} The structural diagnosis from ECM bankers is consistent: Europe relies on a smaller, more selective investor base of mutual funds and hedge funds, with sellers demanding valuations that institutional buyers will not pay.{{cite:85b0d0af0b75}} Family shareholders in KNDS reportedly sought a valuation of at least EUR 12.5 billion — essentially an exit price for a long-term holding — while investors demanded a substantial discount to defense peers to compensate for aftermarket risk.{{cite:85b0d0af0b75}} Without a deeper European investor base including pension funds and broader retail participation, the gap between seller expectations and buyer discipline is likely to persist.{{cite:85b0d0af0b75}}

The Broader ECM Picture

Morgan Stanley frames the current environment as a market rebuilding both depth and breadth. Global equity capital markets issuance rose 43% year over year to $256.8 billion in the first quarter, with IPO volumes up 40% to $45 billion.{{cite:04945a7529d1}} The bank identifies two dominant secular themes driving demand: the large-scale buildout of AI and digital infrastructure, and rising investment across aerospace, defense, and space-related technologies.{{cite:04945a7529d1}}

Two structural shifts are reshaping supply. First, financial sponsors are central: sponsor-backed IPOs have represented roughly a third of U.S. listings in recent years, and PE-backed U.S. IPO issuance reached $12.8 billion in Q3 2025 alone — the strongest period since 2022.{{cite:04945a7529d1}} Second, retail investors are playing a larger role in IPO participation, influencing deal construction and aftermarket dynamics.{{cite:04945a7529d1}}

The IPO recovery is also occurring alongside continued strength in other equity-raise formats. In 2025, global ECM issuance totaled approximately $957 billion, with follow-on offerings raising about $200 billion and convertible issuance reaching roughly $166 billion — together more than one-third of total equity capital raised.{{cite:04945a7529d1}} Convertible issuance has been especially active among companies tied to AI and capital-intensive growth themes, where issuers are balancing funding needs with dilution sensitivity.{{cite:04945a7529d1}}

IPO Pipeline Snapshot

What to Watch Next

• SpaceX Q2 earnings (~August 6): The first post-IPO earnings release doubles as the first lockup window. The performance-based tranche unlocks at $175.50 — 30% above the $135 IPO price — if the stock holds that level for 5 of 10 consecutive trading days.{{cite:7553640c54ae}} Whether the stock is above or below $135 at earnings sets the tone for the entire AI-adjacent issuance complex.

• Anthropic’s public prospectus (expected before October listing): The revenue recognition methodology — specifically how much revenue includes cloud-partner flow-through — will set the valuation benchmark the rest of the AI sector trades against.{{cite:30aad0e27335}} Anthropic’s gross margin disclosure may be the single most important number for the category.

• OpenAI’s decision window: If OpenAI formally defers to 2027, it confirms the market’s view that its $852 billion private valuation does not clear $1 trillion in public markets.{{cite:30aad0e27335}} That signal would ripple across private AI company valuations.

• Lockup absorption mechanics: The 180-day lockup reportedly expires December 8, 2026, with Musk’s 6.4 billion shares locked until June 12, 2027.{{cite:ae6a65d6cb6e}} The pace at which the post-earnings tranche is absorbed — and whether institutional buyers step in at lower prices — will determine whether SPCX transitions to normal float dynamics or remains a scarcity-driven instrument.

• European listing reform progress: The structural gap between U.S. and European IPO health will not close without deeper institutional and retail participation in European markets.{{cite:85b0d0af0b75}} Any movement on pension fund allocation reform or retail access incentives would be the leading indicator to watch.

• Follow-on and convertible pace: With $44.2 billion in follow-ons already raised in Q1 alone{{cite:107436f72202}} and convertible issuance active among AI-adjacent companies,{{cite:04945a7529d1}} the secondary market’s capacity to absorb new equity supply without compression is the quiet liquidity question underlying the entire 2026 issuance surge.